IntrinsicIntrinsic
← Scroll for more →

Financial Statements — EVAX

Balance Sheet

(in millions USD)
MetricQ4 2025Q2 2025Q4 2024Q2 2024Q4 2023Q2 2023Q4 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021
Cash & Equivalents23.2314.755.957.995.587.1213.1825.2531.4132.1711.9418.8026.96
Total Current Assets24.9018.188.7710.708.3511.3716.9928.5335.3834.7116.3223.4332.49
Total Non-current Assets3.514.273.724.534.545.395.045.485.705.467.804.232.43
Total Assets28.4122.4512.4915.2312.8916.7522.0334.0041.0840.1624.1227.6634.92
Total Current Liabilities4.265.324.373.827.084.053.764.414.694.323.924.806.02
Total Non-current Liabilities7.1110.909.7710.1610.5310.179.969.4510.013.403.541.031.11
Total Liabilities11.3716.2214.1413.9817.6214.2213.7213.8514.697.737.475.837.12
Retained Earnings(126.24)(124.95)(118.54)(112.97)(107.97)(84.26)(72.66)(60.33)(55.88)(50.43)(42.14)(37.47)(31.08)
Total Stockholder Equity17.046.23(1.65)1.25(4.73)2.548.3020.1526.3932.4416.6521.8327.80
← Scroll for more columns →

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2025Q2 2024Q2 2023Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Total Revenue0.040.15------------
Research & Development2.172.752.944.114.804.425.113.89
Selling, General & Admin2.211.982.742.151.601.501.921.28
Total Operating Expenses----5.686.266.405.917.035.18
Operating Income(4.34)(4.58)(5.68)(6.26)(6.40)(5.91)(7.03)(5.17)
Interest Expense0.200.19------------
Pretax Income(5.03)(6.40)(5.91)(4.94)(6.04)(5.67)(7.49)(4.50)
Tax Provision(0.19)(0.20)(0.22)(0.18)(0.25)(0.42)(0.67)(0.41)
Net Income(4.83)(6.20)(5.68)(4.77)(5.79)(5.25)(6.82)(4.09)
Basic EPS(0.02)(0.12)(0.21)(0.20)(0.25)------
Diluted EPS----(0.21)(0.20)(0.25)------
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2025Q2 2024Q2 2023Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Operating Cash Flow(7.72)(8.98)(11.29)(13.38)(8.19)(17.82)(11.52)(4.03)
Investing Cash Flow-0.00-0.00(0.03)(0.24)(0.16)(1.15)(0.82)(0.33)
Financing Cash Flow15.5911.395.347.447.7425.1525.2225.25
← Scroll for more columns →